Edoardo Cignoli : Merck Profit Falls on Lower Sales

Merck's third-quarter earnings fell 35% as the loss of exclusivity for asthma and allergy drug Singulair contributed to weaker sales.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304200804579163223426419930.html?mod=pls_whats_news_us_business_f